Photo courtesy: Associated Press
Patients who arrive unconscious, with head injuries, at Seattle’s Harborview Medical Center could become part of a study to see if a drug, TXA, can help prevent bleeding in the brain.
According to the Seattle Times, the drug may be administered without the patient’s consent. Federal law allows that only if researchers adequately inform the community ahead of time. And if they give people a chance to opt out.
TXA has already been approved to stop internal bleeding. The study aims to find if giving the drug as early as possible helps with traumatic brain injury.